Tetrazolylquinazolinones as anti-hyperuricemic agents

Details Tetrazolylquinazolinones as anti-hyperuricemic agents Tetrazolylquinazolinones as anti-hyperuricemic agents

1986-10-14

1988-07-12

Meyers, Albert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31505

Patent

active

047570750

ABSTRACT:
A method of reducing serum levels of uric acid which comprises administration of 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone or its pharmaceutically acceptable salts is described herein.

REFERENCES:
patent: 4419357 (1983-12-01), Peet et al.
patent: 4451467 (1984-05-01), Ishikawa et al.
patent: 4599336 (1986-07-01), Carson et al.
Conn's Current Therapy, pp. 431-433, 1984.
Conn's Current Therapy, pp. 454-457, 1986.

Affiliated with

Also associated with

Rating

Tetrazolylquinazolinones as anti-hyperuricemic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrazolylquinazolinones as anti-hyperuricemic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrazolylquinazolinones as anti-hyperuricemic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-664723